Legal Entity
Insights
Associated Business
Financials
Lookalike companies
FAQ
IPSEN PHARMA SINGAPORE
Last Updated: 31 Jan 2025
We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.
Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries.
For more information, visit ipsen.com.
Pauta exclusiva para México:
Clave de Autorización COFEPRIS: 243300201B1962
CONSULTE A SU MÉDICO.
Country of registration | Singapore |
Registration number | 201603803D |
Local SIC | |
Incorporation date | 16 Feb 2016 |
Company age | 10 years 1 month |
Official entity type | Private Limited Company |
No. of officers | 20 |
Contact
Address:
20 ANSON ROAD, #10-03, TWENTY ANSON, Singapore 079912
Phone number:
Access Key Decision Makers
This is the legal entity page of IPSEN PHARMA SINGAPORE. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (1)
- IPSENView MoreFranceWe are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO.
This is the legal entity page of IPSEN PHARMA SINGAPORE. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Auditor | KPMG LLP |
Revenue | > 10m |
Share Capital - Ordinary shares | SGD 500,000 |
Last updated: 31 Jan 2025
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
- A. MENARINI BIOMARKERS SINGAPORE
- ABBOTT OPERATIONS SINGAPORE PTE. LTD.
- ALLOZYMES PTE. LTD.
- AMGEN BIOTECHNOLOGY SINGAPORE PTE. LTD.
- BIOPROCESSING TECHNOLOGY INSTITUTE
- CELLVEC PTE. LTD.
- CSI MEDICAL RESEARCH PRIVATE LIMITED
- DENKA LIFE INNOVATION RESEARCH PTE. LTD.
- EXPERIMENTAL DRUG DEVELOPMENT CENTRE
- FULLERTON HEALTH VERTO
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of IPSEN PHARMA SINGAPORE?
- Where is IPSEN PHARMA SINGAPORE's headquarter?
- What is IPSEN PHARMA SINGAPORE's contact number?
- What IPSEN PHARMA SINGAPORE's spending power?
- Does IPSEN PHARMA SINGAPORE have a presence in the domain it operates in?